Reviews from the Academic Research Consortium 3 – Coronary Interventions

Published: 08 November 2023

  • Views:

    Views Icon 1276
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

The Academic Research Consortium (ARC) is an international collaborative forum across medical device stakeholders that includes academics, clinical trialists, regulatory bodies and industry.

 

The purpose of the ARC is to create a dynamic, transparent and collaborative forum for stakeholders to develop consensus definitions and standard nomenclature in pivotal clinical trials of medical devices and to disseminate such definitions and recommended processes into the public domain.

 

The ARC-2 initiative (2018) updated the widely used ARC-1 pragmatic consensus definitions for coronary device trials (2007) to incorporate experience gained with the initial definitions, interim recommendations from professional societies, and the expansion of clinical trials to include more complex patient/lesion subsets and novel devices. Coronary research definitions continue to evolve and the ARC-3 initiative is ongoing.

 

This webinar series addresses the hot topics in interventional cardiology, providing state-of-the-art reviews by global leaders from all over the world. Presentations were prepared for the ARC-3 in-person meeting earlier in 2023 and deal with historical and future perspectives. 

 

Learn more about ARC at: www.academicresearchconsortium.org
 

This webinar series is supported by

Key Learning Objectives

  • Discover the existing data, unmet needs, and practical considerations about personalisation of revascularization strategies, either through coronary artery bypass grafting or percutaneous coronary interventions
  • Witness the unprecedented evolution of wire-based physiology, angio-based physiology, and CT-based physiology, for assessment of the severity and clinical relevance of coronary stenosis
  • Explore the strength of coronary imaging data based on ongoing and completed studies in America, Asia, and Europe
  • Learn about the largest studies in coronary physiology and coronary imaging that will determine the future indication and recommendation classes in clinical practice guideline
  • Immerse into the possibilities of registry-based research through the eyes of some of the most notable experts on this topic globally

Target Audience

  • Interventional Cardiologists

More from this programme

Part 1

State-of-The-Art in Coronary Research: Imaging Trials

Part 2

State-of-The-Art in Coronary Research: Physiology Trials

Part 3

State-of-The-Art in Registry-based Research: Imaging and Physiology

Part 4

State-of-The-Art in Coronary Research: CABG vs. PCI Trials

Faculty Biographies

Stefan James

Stefan James

Professor of Cardiology

Prof Stefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital in Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC.

He graduated from Uppsala University Medical School and completed specialist training in Uppsala. He has previously held positions at the Karolinska Hospital, the University Hospital Örebro and Duke Clinical Research Institute, Duke University.

View full profile
José M de la Torre Hernández

José M de la Torre Hernández

Head of Hemodynamics and Interventional Cardiology

Prof Jose M de la Torre is an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, ES.

Prof Jose M de la Torre is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting in US. Faculty of ESC, PCR, ACC and TCT meetings. Coordinator of the ESTROFA, XIMA and LITRO study groups. 

 

View full profile
Shigeru Saito

Shigeru Saito

Director of Cardiology and Catheterisation Laboratories

Dr Shigeru Saito is the Director of Cardiology and Catheterisation Laboratories, at Shonan Kamakura General Hospital in Kamakura, Japan. Dr Saito is one of the leading supporters and practitioners of transradial coronary intervention (TRI) in the world. As an evangelist for TRI, he has travelled the world to teach and demonstrate the benefits and techniques of this alternative to the femoral approach.

One of Dr Saito’s primary activities is to develop a strategy of retrograde approach in coronary angioplasty for chronic total occlusion. He serves as President of NPO International TRI Network. He serves on the editorial boards of Catheterization and Cardiovascular InterventionsJournal of Invasive Cardiology and the International Journal of Cardiology. Dr Saito is widely published in the fields of acute myocardial infarction, cardiomyopathy, coronary angioplasty and the transradial approach.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.